Subscribe free

Metabolic and Bariatric Surgery ·

Impact of Recurrent Weight Gain on Comorbid Conditions Progression Post-Laparoscopic Sleeve Gastrectomy

Recurrent weight gain after laparoscopic sleeve gastrectomy was studied in 122 patients over 2-7 years, showing significant weight loss and comorbidity remission rates. Diabetes, hypertension, and dyslipidemia had substantial remission rates, while a recurrent weight gain ≥ 20% of maximum weight loss indicated comorbidity progression. Healthcare providers can use these findings to implement targeted management strategies for better long-term health outcomes.

Journal Article by Chin WL, Tu WL (…) Hung TT et 3 al. in Obes Surg

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Obes Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →